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1. Introduction
   C-reactive protein (CRP) is a commonly used tool in 
emergency department (ED), especially in febrile and 
equivocal infectious patients. It was identified in 1930 and 
was subsequently classified into an “acute phase protein”, 
an early indicator of infectious or inflammatory situations[1]. 
And then CRP has been considered as a screening test for 
tissue inflammation, a biomarker of disease activity, monitor 
of reflector therapy and as a predictive or prognostic tool of 
many acute and chronic diseases[2,3]. Actually we can not 
distinguish the bacteremia from nonbacteremic infection 
by CRP level, and physicians must take the detailed 
history of fever onset to improve the accurate prediction of 
bacteremia before the results of blood cultures came out[4]. 
Although CRP nowadays is used to be a prognostic and 
predictive factor in acute coronary syndrome, infectious 
and inflammatory diseases, high variability of association 
between an elevated CRP and a bacterial aetiology of the 
infection was poor: sensitivity ranged from 8% to 99% and 
specificity from 27% to 95%[5]. However, it is not used to 
differentiate among the many sources of potential tissue 
destruction. Serial CRP measurements may be helpful to 
monitor a patient’s response to medical intervention. In 
this article, we will review and discuss the CRP value and 
applications in common medical emergencies in ED.
2. Pathophysiology
  CRP has several properties with function of being a 
bacterial opsonin, promoting phagocytosis, accelerating 
chemotaxis, and activating platelets. In the nomination of 
C-reactive protein (CRP), it shows binding reactivity with 
pneumococcal C-polysaccharide, the cell wall carbohydrate 
of Streptococcus pneumoniae, so we called it as C-reactive 
protein[6]. CRP is synthesized by hepatocytes and is 
stimulated by cytokines, particularly IL-6, IL-1, and tumor 
necrosis factor (TNF) after tissue injury or inflammation[7]. 
Levels in healthy individuals are normally less than 1 mg/L, 
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and a value above 10 mg/dL is more likely to indicate when 
patients encounter bacterial, viral or fungal infections or 
tissue inflammation or damage[2]. A cutoff value of 17 mg/dL 
or more for CRP reaches a sensitivity of 74% and a specificity 
of 75% in predicting the existence of infection[8]. The 
functional properties of CRP include the ability to activate 
complement pathway and the ability to modulate the action 
of phagocytic cells. Although CRP rises with tissue injury or 
ischemia, in septic patients with fulminant hepatic failure, 
it is more to be a marker of severe liver dysfunction rather 
than be used as a marker of infection[9].
2.1. Acute coronary syndrome (ACS)
  Acute coronary syndrome (ACS) is a commonly seen 
medical emergency in ED daily practice and it includes 
acute ST elevation myocardial infarcts, non-ST elevation 
myocardial infarcts and unstable angina. Risk factors of 
ACS are hyperlipidemia, smoking, hypertension, diabetes 
mellitus (DM), obesity, low levels of physical activity, family 
history of ACS, and depressive symptoms[10]. There are many 
researches describing elevation of serum C-reactive protein 
(CRP) levels is related to increased risk of myocardial 
infarction[3,11-13]. CRP possesses activation of peripheral 
leukocytes with producing plaque-destabilizing mediators 
and results in infectious diseases trigger manifestations of 
atherosclerosis, in which CRP elevation might lead to the 
onset of cardiovascular events[14]. The earliest research from 
Italy in 1994 reported by Liuzzo and colleagues, and they 
found elevated CRP predicts a poor outcome in patients with 
unstable angina[15]. High-sensitivity CRP (hsCRP) is being 
increasingly used as a tool for cardiac risk evaluation and 
as a prognostic factor in acute coronary syndrome (ACS). In 
the prognosis of ACS, baseline CRP level is an independent 
predictor of both early (30 days) and late (1 year) mortality in 
patients with ACS being intervened with an early invasive 
strategy, especially in Troponin positive patients[16].
  Although the hs-CRP value showing the maximum 
likelihood ratio for predicting cardiac events was 1.45 mg/dL, 
however, in large patient cohort managed in a single-center 
chest pain unit (CPU) (n=958), measurement of hs-CRP did 
not increase the diagnostic accuracy for ACS. Routine hs-
CRP as a diagnostic tool should not be recommended in the 
CPU setting nowadays[17,18]. The important role of CRP in 
CAD after transplanted heart is to intervene with statins by 
reducing CRP, may prevent the severe progression of graft 
atherosclerosis and prolong survival[19]. For ACS, the higher 
CRP levels, the worse prognosis and the higher cardiac 
events possibility. 
2.2. Aortic dissection
  Aortic dissection (AD) is one of the cardiovascular 
emergencies in ED practice. It occurs when the aortic intima 
tears and blood flows into the aortic media creating a false 
lumen. Risky factors include uncontrolled hypertension, 
connective tissue disorders, congenital aortic valve disorder, 
syphilis infection, illicit drug usage and medial degeneration 
of aorta. An Austria study in 2002 suggested elevated 
admission CRP levels in patients with symptomatic aortic 
aneurysm or dissection were independently associated with 
poor prognosis. CRP levels higher than 6.3 mg/dL show a 
high risk for short-term mortality[20]. Increased CRP levels 
were independently associated with mortality. Another study 
from Japan in 2010 concluded peak CRP is a strong predictor 
for adverse long-term events in patients with type B acute 
aortic dissection[21]. For aortic dissection, the higher CRP 
values, the worse prognosis and outcome. 
2.3. Appendicitis
  Acute abdominal pain is a common complaint in ED 
patients and a Taiwan report (n=143) about acute abdominal 
pain concluded elevated CRP along with leukocytosis, the 
diagnostic value was much improved, reaching specificity 
of 89% and positive predictive value of 88%. Thus, CRP 
is a helpful reference for disposition decision-making 
in patients with acute abdominal pain[22]. Diagnosis of 
appendicitis always relies on prudent history taking and 
physical examinations. Some inflammatory parameters 
(such as CRP) could be references in the diagnosis of 
acute appendicitis[23]. A normal CRP along with a normal 
WBC count and normal neutrophil count is unlikely to be 
a case of appendicitis[24]. Although early in the course of 
appendicitis, the white blood cell (WBC) count has shown 
the best diagnostic sensitivity among laboratory tests, 
there are 21% of appendicitis is normal levels of WBC 
count before appendectomy[23]. In appendicitis, after 12-
24 h of symptoms, CRP is deemed to be useful, especially 
when serial levels show an increase. An Ireland report (947 
appendectomies) in 2010, highlight the importance of obesity 
when interpreting the significance of an elevated CRP level 
in children with suspected diagnosis of appendicitis and 
CRP is not a reliable biomarker of inflammation in extremely 
obese children presenting with suspected appendicitis[25]. 
A meta-analysis study (n=3 436) by Hallan concluded CRP 
is an examination of medium accuracy in diagnosing acute 
appendicitis. The sensitivity varied from 0.40 to 0.99, and the 
specificity from 0.27 to 0.90[26]. Although CRP is a marker 
helpful to decision making in acute abdominal pain in the 
ED, we should not make decision in equivocal appendicitis 
case by single CRP level, and computed tomography (CT) 
is a better choice[22]; there is no substitute for serial and 
prudent clinical examinations during an observation period 
for abdominal pain, especially the initial epigastric pain or 
peri-umbilical pain.  
  A study of perforated appendicitis (n=155) from Switzerland 
in 2010 reported hyperbilirubinemia (>20 mmol/L) to be 
a statistically significant marker of perforation in acute 
appendicitis. However, CRP overmatches bilirubin for 
implication of perforation in acute appendicitis[27]. A Taiwan 
report (568 appendectomies) studied the cutoff values of 
CRP concentration taken as the first, second, and third days 
after onset of symptoms that distinguish acute appendicitis 
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from other acute abdominal diseases were 1.5, 4.0, and 10.5 
mg/dL, respectively; the values that distinguish perforated 
appendicitis from other acute abdominal diseases were 
3.3 mg/dL (first day), 8.5 mg/dL (second day), and 12.0 mg/
dL (third day)[28]. From above, CRP is a tool of reference 
in predciting appendicitis and perforated appendicitis. Of 
them, higher CRP level might be found in laboratory data. 
2.4. Cholecystitis 
  There are relative small amount of documents mentioned 
about CRP in cholecystitis. Patients exhibiting one of the 
local signs of inflammation, such as Murphy’s sign, pain or 
tenderness in the right upper quadrant (RUQ), as well as one 
of the systemic signs of inflammation, such as fever, elevated 
white blood cell count (WBC), and elevated C-reactive 
protein level, are diagnosed as having acute Cholecystitis[29]. 
Level of CRP also predicts the severity of acute cholecystitis 
(>10 mg/dL is strongly related to tissue necrosis)[8]. CRP can 
not play a suitable role in diagnosis of cholecystitis, but can 
be a factor indicating severity of cholecystitis and response 
to therapy. 
2.5. Gout
  Not every gout patient had high level exceeding normal 
range of uric acid; similarly, CRP is not a reliable test for 
diagnosis of gout. Patients who had gout and high levels of 
uric acid in their blood did not necessarily also have high 
levels of C-reactive protein. Like that as we all know, not 
every gout patient had hyperuricemia. A Japan study in 2011 
suggests that hyperuricemia may not result in an increase in 
serum CRP level, while benzbromarone may have a favorable 
effect on CRP[30]. 
2.6. Meningitis
  A Finland study in 1999 described seral CRP can 
distinguish Gram negative bacterial meningitis (n=55) 
from viral meningitis (n=182). The mean CRP level in 
Gram negative bacterial meningitis is 11.5 mg/dL, and in 
viral meningitis is less than 2 mg/dL[31]. Compared with 
CRP, procalcitonin can be used in the early diagnosis 
of bacterial meningitis and may be a useful adjunct in 
differentiating bacterial and non bacterial meningitis 
than CRP or leukocyte count and diminishing the value 
of lumbar puncture performed 48-72 h after admission to 
assess treatment efficacy[32]. For meningitis, CRP plays a 
role of distinguishing bacteria from non-bacteria aetiology 
infection. 
2.7. Pancreatitis
  CRP might be valuable in the assessment and monitoring 
of acute pancreatitis. C reactive protein response and its 
rate of change in acute pancreatitis reflect different severity. 
Higher concentrations of C reactive protein (>10mg/dL) 
were sustained in severe attacks, and give a warning of the 
following severe local inflammation in the patient whose 
initial illness is relatively mild and whose clinical course 
is initially benign[33]. Erythrocyte sedimentation rate (ESR) 
can predict severe acute pancreatitis with a slightly inferior 
performance to CRP. Combined ESR and CRP at 24 h
can predict severe acute pancreatitis accurately[5]. For 
pancreatitis, CRP is a tool of evaluation in severity rather 
than making diagnosis. 
2.8. Pelvic inflammatory disease
  Currently C-reactive protein is used in the management of 
chorioamnionitis, preterm premature rupture of membranes, 
pelvic inflammatory disease (PID), and urinary tract infection 
(UTI) in gynecology[34]. A Slovenia study in 1998 documented 
96.1% of pelvic inflammatory disease (PID) patients had 
increased CRP values. In successful treatment, the CRP 
values decreased significantly in PID patients without 
tubo-ovarian abscess (TOA) on day 3-4, in patients with 
TOA on day 6-8 and reached normal values in both groups 
on day 18-21. Improves in clinical condition were most 
concurrent with decreases in CRP values[35]. Another study 
from Finland in 1987 reported 55 PID cases had the mean 
CRP level of 7.6 mg/dL. CRP greater than 1 mg/dL had good 
sensitivity (93%) and specificity (83%) in the diagnosis of PID. 
Furthermore, CRP levels became normal much sooner than 
did erythrocyte sedimentation rate (ESR) following effective 
antibiotic therapy, suggesting that it is useful in monitoring 
therapeutic response[36]. For PID, CRP is a tool of monitoring 
therapeutic efficacy. 
2.9. Pneumonia
  There are many aspects and tools to diagnose pneumonia 
including history taking, chest X ray, auscultation of 
breathing sound or high resolution computed tomography 
(HRCT). Composition of some parameters/blood tests such 
as white blood cell count (WBC) and CRP are adjuvant 
and helpful to diagnosis. For pneumonia, CRP plays the 
roles of prognosis prediction and therapy reflector rather 
than making diagnosis. An UK study in 2008 studied 570 
pneumonia cases, and found admission CRP<10 mg/dL has 
reduced risk for 30-day mortality, need for mechanical 
ventilation and/or inotropic support, and complicated 
pneumonia. Failure of CRP to fall by 50% or more at day 
4 leads to an increased risk for 30-day mortality, need 
for mechanical ventilation and/or inotropic support, and 
complicated pneumonia. CRP is an independent biomarker 
of severity in community-acquired pneumonia[37]. A Brazil 
study in 2010 documented daily CRP measurements in 
patients with nosocomial pneumonia may be useful in the 
prediction of patients with poor outcome, and detect patients 
with inappropriate antimicrobial therapy[38].
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2.10. Sepsis
  Sepsis is the major cause of mortality in critically ill 
patients and physicians encountered it in ED and intensive 
care unit (ICU) in daily practice. Although CRP is used to be 
a monitoring factor for complication or treatment failure, it 
is not reliable and meaningful in the early post-operative 
period. Tissue damages may lead to pseudo-elevation 
of CRP rather than sepsis. A Brazil study in 2009 did not 
show any correlation between CRP and infection among 
patients with systemic inflammatory response syndrome 
(SIRS) and septic shock during the early postoperative 
period[39]. C-reactive protein is a valuable laboratory test in 
the assessment of febrile infants aged ≤3 months old and 
may serve as a better diagnostic marker of serious bacterial 
infection (SBI) than total WBC count[40]. For the diagnosis 
of late-onset neonatal sepsis (LONS), the procalcitonin 
(PCT) test showed better accuracy than the CRP test[41]. 
Procalcitonin (PCT) has emerged as the most studied and 
promising sepsis biomarker. For diagnostic and prognostic 
purposes in critical care, PCT is superior to CRP and other 
traditional markers of sepsis[42].
2.11. Stroke
  Elevation of CRP is obviously seen after ischemic stroke 
attack than intracranial hemorrhage (ICH). Brain tissue 
ischemia and damage result in surge of CRP after stroke 
episode. Prudent physical examinations and review of 
systems are helpful to detect other infectious condition co-
incidence stroke. An Iran study in 2011 reported serum 
level of hs-CRP in ischemic patients was higher than 
in hemorrhagic group (18.92 mg/dL vs. 2.65 mg/dL). Hs-
CRP might be considered as a helpful method for the 
initial diagnosis of the type of stroke (ischemic infarcts 
or hemorrhagic)[43]. Higher WBC, CRP, and blood glucose 
are associated with increased mortality in spontaneous 
intracranial hemorrhage (sICH) patients. Only CRP elevation 
portends higher risk of death independently of other 
indicators of sICH severity[44]. CRP is a marker of increased 
1-year risk in ischemic stroke. CRP at discharge is better 
related to later outcome and could be of greater utility for 
risk stratification. These findings are consistent with that 
elevated CRP may predict future cardiovascular events or 
death[45].
2.12. Urinary tract infection
  Urinary tract infection (UTI) is a commonly seen disease 
in ED daily practice. An elevated serum CRP concentration 
is not accurate in localizing the site of a urinary tract 
infection in girls who do not have clinical signs of acute 
pyelonephritis[46]. ESR and differential leukocyte count 
are two valuable tests in febrile UTI and may be useful for 
localization of UTI level, but the total leukocyte count and 
CRP level as in qualitative methods are not useful, and many 
patients with febrile UTI do not have leukocytosis[47]. 
3. Summary
  In the ED, CRP must be a diagnostic reference and no 
single value can be indicated to rule in or rule out a 
specific diagnosis or disease. CRP is a comprehensively 
assisted tool for evaluation and diagnosis of tissue damage 
(rheumatologic diseases, cancer, pancreatitis, burn injury, 
sepsis) and infection (urinary tract infection, pelvic 
inflammatory disease, lung infection). It can be used for 
treatment monitoring and severity evaluation in pneumonia, 
pancreatitis, pelvic inflammatory disease (PID), and urinary 
tract infections (UTI). C-reactive protein adds little to 
the diagnosis of pneumonia, urinary tract infections, and 
pancreatitis. A single CRP value should not straightly make 
the decision to treat these patients. That is, CRP has no 
role in diagnosing these clinical entities, and a normal CRP 
level should never delay antibiotic coverage in ED. Faster 
and more interpretable tools such as image studies (X-ray, 
sonography and computed tomography) are available to help 
diagnose suspected cases of aortic dissection, appendicitis, 
cholecystitis, pancreatitis, pneumonia and stroke in ED. 
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